Literature DB >> 16534846

Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli.

Karlheinz Kiehne1, Gabriele Brunke, Franziska Wegner, Tomas Banasiewicz, Ulrich R Folsch, Karl-Heinz Herzig.   

Abstract

AIM: Pouchitis develops in ileoanal pouches in up to 50% of patients with ulcerative colitis during the first 10 years after pouch surgery while being rare in patients after proctocolectomy for familial adenomatous polyposis coli (FAP) syndrome. Defensins are major components of the innate immune system and play a significant role in gastrointestinal microbial homeostasis. Pouch defensin and cytokine expression were correlated with states of pouch inflammation to study their role in pouchitis.
METHODS: Patients with ulcerative colitis and FAP syndrome were stratified into groups with pouches after surgery, pouches without or with pouchitis. Biopsies from terminal ileum from a healthy intestine or from normal terminal ileum of patients with ulcerative colitis served as controls. mRNA from pouches and controls was analysed for defensin and cytokine expression.
RESULTS: Expression of defensins was increased in all pouches immediately after surgery, compared to ileum of controls. Initially, pouches in ulcerative colitis revealed higher defensin expression than FAP pouches. Defensin expression declined in both patient groups and increased again slightly in pouchitis in patients with ulcerative colitis. FAP pouches without pouchitis had strong expression of beta-defensin hBD-1, while all other defensins remained at low levels. Cytokine expression in ulcerative colitis pouches was high, while FAP pouches showed moderately elevated cytokines only after surgery.
CONCLUSION: Development of pouchitis correlates with decreased defensin expression in ulcerative colitis in addition to high expression of cytokines. The low incidence of pouchitis in FAP pouches correlates with increased expression of hBD-1 beta-defensin in association with low cytokine levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16534846      PMCID: PMC4087897          DOI: 10.3748/wjg.v12.i7.1056

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum.

Authors:  P Rutgeerts; K Goboes; M Peeters; M Hiele; F Penninckx; R Aerts; R Kerremans; G Vantrappen
Journal:  Lancet       Date:  1991-09-28       Impact factor: 79.321

2.  Effects of the faecal stream and stasis on the ileal pouch mucosa.

Authors:  H J de Silva; P R Millard; N Soper; M Kettlewell; N Mortensen; D P Jewell
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

3.  Qualitative assessment and morphometry in the study of the ileal reservoir after restorative proctocolectomy.

Authors:  F P Reinholt; B Veress; K Lindquist; L Liljeqvist
Journal:  APMIS       Date:  1989-02       Impact factor: 3.205

4.  Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.

Authors:  W J Sandborn; W J Tremaine; K P Batts; J H Pemberton; S F Phillips
Journal:  Mayo Clin Proc       Date:  1994-05       Impact factor: 7.616

5.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.

Authors:  S J Ott; M Musfeldt; D F Wenderoth; J Hampe; O Brant; U R Fölsch; K N Timmis; S Schreiber
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

6.  Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.

Authors:  H C Reinecker; M Steffen; T Witthoeft; I Pflueger; S Schreiber; R P MacDermott; A Raedler
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

7.  Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis.

Authors:  M V Madden; A S McIntyre; R J Nicholls
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

8.  Pouchitis: result of microbial imbalance?

Authors:  J G Ruseler-van Embden; W R Schouten; L M van Lieshout
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

9.  Distribution of mucosal pathology and an assessment of colonic phenotypic change in the pelvic ileal reservoir.

Authors:  N A Shepherd; C J Healey; B F Warren; P I Richman; W H Thomson; S P Wilkinson
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

10.  Differential gene induction of human beta-defensins (hBD-1, -2, -3, and -4) in keratinocytes is inhibited by retinoic acid.

Authors:  Jürgen Harder; Ulf Meyer-Hoffert; Kai Wehkamp; Lars Schwichtenberg; Jens-Michael Schröder
Journal:  J Invest Dermatol       Date:  2004-09       Impact factor: 8.551

View more
  10 in total

1.  Activation of signal transducer and activator of transcription-1 (STAT-1) and differential expression of interferon-gamma and anti-inflammatory proteins in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis.

Authors:  R F Leal; M L S Ayrizono; M Milanski; A Coope; J J Fagundes; L A Velloso; C S R Coy
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

2.  Innate immune environment in ileal pouch mucosa: α5 defensin up-regulation as predictor of chronic/relapsing pouchitis.

Authors:  Marco Scarpa; Alessia Grillo; Melania Scarpa; Paola Brun; Carlo Castoro; Anna Pozza; Donatella Cavallo; Diego Faggian; Cesare Ruffolo; Renata D'Incà; Romeo Bardini; Ignazio Castagliuolo; Imerio Angriman
Journal:  J Gastrointest Surg       Date:  2011-10-08       Impact factor: 3.452

Review 3.  Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis.

Authors:  Imerio Angriman; Marco Scarpa; Ignazio Castagliuolo
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  Differential expression of TLR2, TLR4 and JNK in mucosa of ileal pouches for ulcerative colitis. Is there a role for bacterial antigen pathway in asymptomatic patients?

Authors:  Nielce M de Paiva; Maria L S Ayrizono; Marciane Milanski; Andressa Coope; Luiza M F Oliveira; João J Fagundes; Lício A Velloso; Cláudio S R Coy; Raquel F Leal
Journal:  Int J Clin Exp Med       Date:  2011-09-15

Review 5.  Pouchitis: insight into the pathogenesis and clinical aspects.

Authors:  Leandro Minatel Vidal de Negreiros; Lívia Bitencourt Pascoal; Lívia Moreira Genaro; Julian Furtado Silva; Bruno Lima Rodrigues; Michel Gardere Camargo; Carlos Augusto Real Martinez; Cláudio Saddy Rodrigues Coy; Maria de Lourdes Setsuko Ayrizono; João José Fagundes; Raquel Franco Leal
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

6.  Detection of epithelial apoptosis in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis.

Authors:  Raquel F Leal; Maria de Lourdes S Ayrizono; Marciane Milanski; João J Fagundes; Juliana C Moraes; Luciana R Meirelles; Lício A Velloso; Cláudio S R Coy
Journal:  J Transl Med       Date:  2010-01-29       Impact factor: 5.531

7.  Differential expression of pro-inflammatory cytokines and a pro-apoptotic protein in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis.

Authors:  R F Leal; C S R Coy; M L S Ayrizono; J J Fagundes; M Milanski; M J Saad; L A Velloso; J R N Góes
Journal:  Tech Coloproctol       Date:  2008-05-30       Impact factor: 3.781

8.  Dysregulation of human beta-defensin-2 protein in inflammatory bowel disease.

Authors:  Marian C Aldhous; Colin L Noble; Jack Satsangi
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

9.  Ganglioside Alters Phospholipase Trafficking, Inhibits NF-κB Assembly, and Protects Tight Junction Integrity.

Authors:  John J Miklavcic; Qun Li; Jordan Skolnick; Alan B R Thomson; Vera C Mazurak; Micheal Tom Clandinin
Journal:  Front Nutr       Date:  2021-07-05

10.  Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease.

Authors:  Maureen J Koslowski; Irmgard Kübler; Mathias Chamaillard; Elke Schaeffeler; Walter Reinisch; Guoxing Wang; Julia Beisner; Alexander Teml; Laurent Peyrin-Biroulet; Stefan Winter; Klaus R Herrlinger; Paul Rutgeerts; Séverine Vermeire; Rachel Cooney; Klaus Fellermann; Derek Jewell; Charles L Bevins; Matthias Schwab; Eduard F Stange; Jan Wehkamp
Journal:  PLoS One       Date:  2009-02-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.